11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft

11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft

Core Knowledge: In extensive major thermal injuries ($>40%\text{ to }50%\text{ TBSA}$), full-thickness wound excision rapidly exhausts the patient's available autologous donor skin. Under these life-threatening circumstances, the burn team must deploy temporary biological coverings and engineered dermal regeneration templates to achieve immediate physiological wound closure. The Certified Burn Registered Nurse (CBRN) must master the biological mechanics, staged surgical workflows, color maturation indicators, and complication management associated with these advanced skin substitutes.

---

1. Classification & Roles of Skin Substitutes

Skin substitutes are classified across multiple clinical and structural dimensions: temporary vs. permanent, biological vs. synthetic, and cellular vs. acellular.

                      SPECTRUM OF SKIN SUBSTITUTES
  ┌────────────────────────────────────────────────────────────────────────┐
  │ [1] TEMPORARY BIOLOGICAL COVERINGS (Bridge to Autografting)           │
  │     • Allograft (Homograft): Cryopreserved/fresh cadaveric skin        │
  │     • Xenograft (Heterograft): Porcine skin                            │
  │     • Amniotic Membrane: Human placental membrane                      │
  ├────────────────────────────────────────────────────────────────────────┤
  │ [2] DERMAL REGENERATION TEMPLATES (Engineered Scaffolds)               │
  │     • Integra Bilayer Matrix: Bovine collagen + GAG + Silicone layer   │
  │     • Novosorb BTM: Biodegradable synthetic polyurethane foam + Film   │
  │     • Matriderm: Bovine collagen + elastin matrix (single-stage STSG)  │
  │     • AlloDerm: Acellular human cadaveric dermal matrix (ADM)          │
  ├────────────────────────────────────────────────────────────────────────┤
  │ [3] PERMANENT CELLULAR / EPIDERMAL REPLACEMENTS                        │
  │     • Autologous Split-Thickness Skin Graft (STSG) / FTSG              │
  │     • Cultured Epithelial Autografts (CEA / Epicel)                    │
  │     • Autologous Cell Suspension (ReCell)                              │
  └────────────────────────────────────────────────────────────────────────┘

Physiological Functions of Immediate Wound Coverage

Whether temporary or permanent, closing an open excised burn wound achieves vital homeostatic goals:

1. Restores the Evaporative Barrier: Halts massive insensible water loss (which can exceed $3,000\text{ to }5,000\text{ mL/m}^2\text{/day}$ in open burns) and terminates evaporative heat loss, preserving core body temperature.
2. Halts Protein & Electrolyte Exudation: Prevents continuous transudative loss of albumin, immunoglobulins, and micronutrients across raw capillary beds.
3. Eliminates Pain: Protects exposed dermal nerve terminals from ambient airflow, temperature shifts, and mechanical friction.
4. Suppresses Microbial Proliferation: Re-establishes a physical barrier that prevents airborne pathogen deposition and reduces surface colonization.
5. Stimulates Angiogenesis: Releases cytokines and growth factors that prepare suboptimal wound beds for future autografting.

---

2. Temporary Biologic Coverings: Allograft vs. Xenograft

Allograft (Homograft / Cadaveric Skin)

Allograft is harvested from human cadaveric donors within 24 hours of death, screened rigorously for infectious diseases (HIV, Hepatitis B/C, Syphilis), and preserved via cryopreservation (liquid nitrogen at $-196^\circ\text{C}$) or glycerol preservation.

• Biological Integration: Allograft is the gold-standard temporary biological covering. It undergoes true biological plasmatic imbibition and capillary inosculation, establishing functional microvascular blood flow with the host recipient bed within 48 to 72 hours.
• Clinical Indications:
  • Immediate temporary coverage of massive excised burn wounds when autograft donor sites are unavailable.
  • The "Test Graft": Applied to questionable, heavily colonized, or freshly debrided wound beds to verify bacterial control and vascular readiness. If the allograft "takes" (becomes pink and adherent), the wound bed is deemed ready for definitive autografting.
  • Sandwich Technique (Alexander Technique): Applied as an unmeshed or 1:1.5 meshed sheet directly over widely meshed (1:3 to 1:6) autografts. The allograft protects the open interstitial diamond gaps from desiccation and infection while autologous keratinocytes migrate beneath it.
• Rejection Timeline: Because cadaveric skin expresses foreign Human Leukocyte Antigens (HLA Class I and II) on epidermal and endothelial cells, the recipient's cell-mediated immune system (CD4+ and CD8+ T lymphocytes) mounts an acute rejection response. Cryopreserved allograft undergoes immune rejection typically within 14 to 21 days (fresh allograft rejects in 7 to 10 days; immunosuppressed patients may retain it for 4 to 6 weeks). The allograft must be surgically excised or stripped before necrotic rejection leads to suppurative wound infection.

Xenograft (Heterograft / Porcine Skin)

Xenograft is harvested from animal sources, predominantly porcine (pig) dermis and epidermis, and processed via lyophilization (freeze-drying) or glutaraldehyde cross-linking.

• Biological Behavior: Xenograft does NOT undergo vascular inosculation or establish direct blood flow with the host bed. It adheres mechanically via fibrin bonding to provide a biological "bandage."
• Clinical Indications: Clean, superficial to mid-dermal partial-thickness burns (especially pediatric scalds), donor sites, and temporary coverage of cleanly debrided wounds awaiting immediate autografting.
• Nursing Management & Complications: Because xenograft does not revascularize, it rapidly desiccates and hardens. It must be removed and replaced every 3 to 5 days. If left in place too long, host leukocyte infiltration and bacterial proliferation beneath the non-viable pig skin trigger severe sub-dressing suppuration and wound conversion.

Comparative Analysis: Allograft vs. Xenograft

---

3. Dermal Regeneration Templates: Integra Bilayer Matrix

Integra Bilayer Wound Matrix is an advanced, acellular dermal regeneration template designed to reconstruct a functional, permanent neodermis in deep partial- and full-thickness burns where native dermis has been completely destroyed.

                    INTEGRA BILAYER MATRIX ARCHITECTURE
  
  [ Temporary Layer ]  ══════════════════════════════════════ ◄── 0.1 mm Polysiloxane (Silicone)
                       (Mechanical seal, moisture barrier)
  
  [ Dermal Template ]  ▒ ▒ ▒ ▒ ▒ ▒ ▒ ▒ ▒ ▒ ▒ ▒ ▒ ▒ ▒ ▒ ▒ ▒ ▒ ◄── Bovine Collagen Type I +
                       (Porous scaffold 70–120 μm;          Chondroitin-6-Sulfate (GAG)
                        host fibroblasts & vessels invade)
  ════════════════════ ══════════════════════════════════════
  [ Excised Bed ]      ██████████████████████████████████████ ◄── Healthy viable wound bed

Structural Anatomy and Mechanism

• The Inner Dermal Layer (Scaffold): A 1.0 to 2.0 mm thick porous matrix composed of cross-linked bovine tendon Type I collagen and glycosaminoglycan (chondroitin-6-sulfate) derived from shark cartilage, with a calibrated pore size of 70 to 120 microns. When placed on an excised wound, host fibroblasts, macrophages, and capillary endothelial cells migrate into the scaffold. Over 2 to 3 weeks, host fibroblasts deposit endogenous human collagen while endogenous enzymes slowly biodegrade the bovine matrix, creating a living, vascularized "neodermis."
• The Outer Epidermal Layer (Silicone): A 0.1 mm semi-permeable polysiloxane (silicone) membrane bonded to the collagen. It functions as a temporary synthetic epidermis, controlling water vapor loss, providing mechanical strength, and barring bacterial invasion.

Staged Surgical Protocol & Color Maturation

Integra requires a structured two-stage surgical procedure separated by a 2- to 3-week neovascularization window:

                    TWO-STAGE INTEGRA SURGICAL WORKFLOW
  ┌────────────────────────────────────────────────────────────────────────┐
  │ STAGE 1: Surgical Excision & Template Fixation (Day 0)                 │
  │ • Radical or tangential excision down to pristine, viable tissue       │
  │ • Apply Integra matrix; fix with staples or sutures                    │
  │ • Bolster dressing or Negative Pressure Wound Therapy (NPWT at -125)   │
  ├────────────────────────────────────────────────────────────────────────┤
  │ INTERMEDIATE NEOVASCULARIZATION PHASE (Days 1 to 21)                   │
  │ • Days 1–7:  Matrix appears reddish-pink (erythrocyte penetration)     │
  │ • Days 7–14: Matrix transitions to pale yellow / amber                 │
  │ • Days 14–21:Matrix becomes PEACH / SALMON / APRICOT (mature neodermis)│
  │ • Capillary refill visible through translucent silicone                │
  ├────────────────────────────────────────────────────────────────────────┤
  │ STAGE 2: Silicone Delamination & Thin Autografting (Days 14 to 21)     │
  │ • Remove surgical staples along margins                                │
  │ • Gently peel/delaminate the silicone membrane from the neodermis      │
  │ • Harvest and apply an ULTRA-THIN STSG (0.004 to 0.006 inches)         │
  │ • Secure with bolster or NPWT; rapid epithelial take occurs in 3–5 days│
  └────────────────────────────────────────────────────────────────────────┘

Complications and Nursing Management of Integra

1. Sub-Silicone Seroma and Hematoma Accumulation:
   • Pathology: Blood or serous fluid collects between the silicone sheet and the collagen matrix, separating the silicone and creating a high risk for infection and matrix failure.
   • Nursing Intervention: Inspect the template daily. If fluid collects, perform sterile aspiration or fenestration using an 18- or 20-gauge needle or small micro-slit with a #11 blade over the collection. Gently express the fluid with a sterile cotton swab and re-apply compressive bolster dressings.
2. Infection and Matrix Lysis:
   • Pathology: Bacterial colonization beneath the silicone releases proteases that rapidly lyse the collagen scaffold. Infection is recognized by a transition of the matrix from peach/salmon to cloudy gray, dark brown, or green, accompanied by foul odor, purulence, and spontaneous floating of the silicone layer.
   • Nursing Intervention: Infection mandates immediate surgical notification, localized or complete removal (delamination) of the infected silicone/matrix, wound culture collection, and initiation of topical antimicrobial soaks (e.g., silver nitrate 0.5%, mafenide acetate 5% solution, or dilute sodium hypochlorite/Dakin's solution).

---

4. Synthetic Biodegradable Templates: Novosorb BTM

Novosorb Biodegradable Temporizing Matrix (BTM) is a fully synthetic, open-cell polyurethane dermal scaffold designed to overcome the biological limitations and infection risks of animal-derived matrices.

• Composition: Composed entirely of a biodegradable polyurethane open-cell foam (with interconnecting 200–300 micron pores) bonded to a non-porous temporary polyurethane sealing membrane. Contains zero biological or animal-derived components, eliminating risks of prion transmission or religious/cultural objections.
• Key Clinical Advantage (Infection Resilience): Unlike collagen matrices (which dissolve rapidly when exposed to bacterial proteases), Novosorb BTM is highly resistant to microbial degradation. If localized infection occurs, the template does not lyse; the silicone/polyurethane seal can be fenestrated, the collection irrigated with antimicrobial solutions, and the synthetic scaffold preserved while tissue ingrowth continues.
• Integration & Staging: Host fibrovascular tissue integrates through the polyurethane foam over 3 to 4 weeks (21 to 28 days). Once fully integrated (demonstrating a robust, vascularized red tissue bed with positive capillary refill), the sealing membrane is delaminated, the superficial surface lightly dermabraded or debrided, and an ultra-thin STSG (0.005 to 0.008 inches) is applied.

---

5. Nursing Surveillance Protocols for Dermal Templates

• Continuous Bolster Maintenance: Dermal templates require continuous, uniform contact with the recipient wound bed. Negative Pressure Wound Therapy (NPWT at continuous $-75\text{ to }-125\text{ mmHg}$) is the gold-standard dressing over Integra and BTM. Ensure the NPWT seal is airtight; loss of vacuum allows shear motion and fluid pooling.
• Shear Stress Mitigation: Prevent any friction or shearing forces across the template during patient transfers, repositioning, or linen changes. Keep adjacent joints rigidly splinted in anti-deformity positions until Stage 2 autografting is complete.
• Systematic Color Tracking: Document the chronological color progression of the matrix every shift (from initial red, to pale yellow, to mature peach/salmon). Any sudden appearance of dark maroon, black, cloudy gray, or yellow-green exudate must be escalated immediately.